AP2011005679A0 - Drop pill for treating coronary heart disease and preparation thereof. - Google Patents

Drop pill for treating coronary heart disease and preparation thereof.

Info

Publication number
AP2011005679A0
AP2011005679A0 AP2011005679A AP2011005679A AP2011005679A0 AP 2011005679 A0 AP2011005679 A0 AP 2011005679A0 AP 2011005679 A AP2011005679 A AP 2011005679A AP 2011005679 A AP2011005679 A AP 2011005679A AP 2011005679 A0 AP2011005679 A0 AP 2011005679A0
Authority
AP
ARIPO
Prior art keywords
preparation
heart disease
coronary heart
drop pill
treating coronary
Prior art date
Application number
AP2011005679A
Other languages
English (en)
Inventor
Jianming Chen
Xijun Yan
Baoan Gao
Original Assignee
Tianjin Tasly Pharmceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Tasly Pharmceutical Co Ltd filed Critical Tianjin Tasly Pharmceutical Co Ltd
Publication of AP2011005679A0 publication Critical patent/AP2011005679A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
AP2011005679A 2008-10-06 2009-09-30 Drop pill for treating coronary heart disease and preparation thereof. AP2011005679A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN200810152009 2008-10-06
PCT/CN2009/074339 WO2010043156A1 (zh) 2008-10-06 2009-09-30 一种治疗冠心病的滴丸及其制备方法

Publications (1)

Publication Number Publication Date
AP2011005679A0 true AP2011005679A0 (en) 2011-04-30

Family

ID=42106231

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2011005679A AP2011005679A0 (en) 2008-10-06 2009-09-30 Drop pill for treating coronary heart disease and preparation thereof.

Country Status (8)

Country Link
US (1) US20110195136A1 (xx)
AP (1) AP2011005679A0 (xx)
AU (1) AU2009304440A1 (xx)
BR (1) BRPI0920617A2 (xx)
CA (1) CA2738614A1 (xx)
IL (1) IL212018A0 (xx)
MX (1) MX2011003647A (xx)
WO (1) WO2010043156A1 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102657730A (zh) * 2012-06-05 2012-09-12 西藏天力商贸有限公司 一种抗高原反应的红景天口含剂
CN102940694B (zh) * 2012-10-31 2014-06-25 成都医路康医学技术服务有限公司 一种治疗心脑血管病的药物组合物
CN103735617A (zh) * 2013-12-13 2014-04-23 王树林 复方丹参口腔崩解片及其制备方法
CN103800482B (zh) * 2014-03-06 2015-08-12 李兵晖 一种治疗心肌缺血的药物组合物及其制备方法和应用
CN104374844A (zh) * 2014-11-13 2015-02-25 贵州信邦制药股份有限公司 丹参药材中水溶性成分的含量测定方法及其应用
CN106483260A (zh) * 2015-10-09 2017-03-08 厦门中药厂有限公司 一种八宝丹胶囊质量标准控制方法
CN106420836B (zh) * 2016-06-24 2019-10-25 孙彪 一种林蛙油滴丸及其制备方法
CN107596146A (zh) * 2017-10-26 2018-01-19 张纪星 一种治疗冠状动脉粥样硬化和脑血管硬化疾病的中药复方
CN108888707A (zh) * 2018-07-13 2018-11-27 安徽松山堂国药股份有限公司 一种银杏滴丸剂及其制备方法
CN110243988B (zh) * 2019-06-28 2021-09-14 广西中医药大学 壮药白花九里明hplc指纹图谱的建立方法
CN111068368A (zh) * 2020-01-15 2020-04-28 开封嘉骏生物科技有限公司 一种用于沉淀畜禽用中药提取液中杂质的组方及其应用
CN112946118B (zh) * 2021-02-01 2023-04-07 贵州金桥药业有限公司 一种药物指纹图谱的测定方法及其指纹图谱

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1161140C (zh) 2001-11-09 2004-08-11 天津天士力制药股份有限公司 一种预防和治疗冠心病心绞痛的药物及其制备方法和其它用途
CN100553615C (zh) * 2003-12-11 2009-10-28 天津天士力制药股份有限公司 一种治疗心脑血管疾病的药物
CN1785247B (zh) * 2004-12-06 2010-08-11 天津天士力制药股份有限公司 一种崩解片及其制备方法

Also Published As

Publication number Publication date
BRPI0920617A2 (pt) 2015-12-22
AU2009304440A1 (en) 2010-04-22
IL212018A0 (en) 2011-06-30
MX2011003647A (es) 2011-05-25
WO2010043156A1 (zh) 2010-04-22
CA2738614A1 (en) 2010-04-22
US20110195136A1 (en) 2011-08-11

Similar Documents

Publication Publication Date Title
AP2011005679A0 (en) Drop pill for treating coronary heart disease and preparation thereof.
HUS1600048I1 (hu) Készítmény Fabry-kór kezelésére
GB2465897B (en) Respiratory disease treatment
IL225637A0 (en) The compositions, tablets containing such compositions, their use and a process for their preparation
PT2376537T (pt) Anticorpos humanos contra fator tecidual humano
ZA201000588B (en) Improved pharmaceutical-coated medical products,the production thereof and the use thereof
EP2443449A4 (en) DETERMINATION OF CORONARY ARTERY DISEASE RISK
ZA200805939B (en) Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
ZA201101369B (en) Multilayered blood product
IL192809A0 (en) Compositions and methods for treating cardiovascular, cerebrovascular and other vascular disease patients
PL2234631T3 (pl) Związki i metody stosowane w terapii choroby naczyniowej
GB0707208D0 (en) Novel disease treatments
EP2393503A4 (en) AYURVEDA FORMULATION FOR THE TREATMENT OF CORONARY DISEASES
GB0701456D0 (en) Treatment for respiratory disease
GB2447884B (en) Treatment for skin disease
ZA201005394B (en) 15,16-methylene-17-hydroxy-19-nor-21-carboxylic acid y-lactone derivative,use thereof,and medicament containing said derivative
EP2190990A4 (en) PTHRP, its isoforms and antagonist for the diagnosis and treatment of diseases
GB0823568D0 (en) Respiratory disease treatment
GB0814488D0 (en) Respiratory disease treatment
GB0604130D0 (en) Treatment for skin disease
TWI372054B (en) A pharmaceutical composition for preventing or treating cardiovascular disease
GB0721923D0 (en) Novel compounds and improved treatments for cardiac and cardiovascular disease
GB0700577D0 (en) Composition for heart disease
GB0821490D0 (en) Molecular methods for the treatment of disease.
HU0500437D0 (en) Medicine against heart burn